Biolegend, 141707, APC anti-mouse CD206 (MMR) Antibody, 25μg

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Recombinant mouse CD206 (MMR)
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality testedFC - Verified
Recommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
Application References(PubMed link indicates BioLegend citation): Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed Yang X, et al. 2015. PNAS. 112:2900. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Liu J, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.139. PubMed Wang C, et al. 2018. J Pharmacol Exp Ther. 365:72. PubMed Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed Song X, et al. 2022. Int J Mol Sci. 23:. PubMed Wu Y, et al. 2023. Adv Mater. 35:e2210787. PubMed Sheng Y, et al. 2023. Cancers (Basel). 15:. PubMed Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed Lu Y, et al. 2023. J Transl Med. 21:339. PubMed Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed Liu C, et al. 2022. Regen Ther. 21:192. PubMed Miki H, et al. 2020. J Immunol. 204:1892. PubMed Zhou Y, et al. 2022. Br J Pharmacol. 179:1978. PubMed Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed Chang S, et al. 2022. Phytother Res. 36:1678. PubMed Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed Wu J, et al. 2023. Bioact Mater. 20:259. PubMed Poh AR, et al. 2022. Sci Adv. 8:eabl7882. PubMed Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed Lin J, et al. 2022. Eur J Histochem. 67: . PubMed Sun J, et al. 2023. Mediators Inflamm. 2022:1108569. PubMed Ye Z, et al. 2023. Front Med (Lausanne). 9:1075465. PubMed De Schepper S, et al. 2023. Nat Neurosci. 26:406. PubMed Kimura Y, et al. 2023. Front Immunol. 14:1070196. PubMed Liang P, et al. 2022. Prostate Cancer Prostatic Dis. 25:539. PubMed Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed Jeong J, et al. 2017. Sci Rep. 7:39848. PubMed Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed Liu C, et al. 2019. J Transl Med. 17:300. PubMed Zhang X, et al. 2017. J Cell Mol Med. 10.1111/jcmm.13329. PubMed Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed He J, et al. 2022. Front Immunol. 12:760138. PubMed Giordano C, et al. 2014. Hum Mol Genet. . PubMed Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed Tahiri H, et al. 2016. Sci Rep. 6:37391. PubMed Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed Chang CF, et al. 2017. Neurobiol Dis. 103:54. PubMed Pilch Z, et al. 2018. Cancer Immunol Res. 6:930. PubMed Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed Young JA, et al. 2020. Journal of Neuroendocrinology. e12854.. PubMed Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed Nawaz A, et al. 2022. Nat Commun. 13:7058. PubMed Zhang L, et al. 2022. Acta Pharm Sin B. 12:3427. PubMed Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed Trott DW, et al. 2021. Geroscience. 43:1331. PubMed Wada N, et al. 2020. Mol Metab. 37:100988. PubMed Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed Motoyama S, et al. 2020. Cells. :9. PubMed Li S, et al. 2021. Ann Transl Med. 9:1644. PubMed Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed Helm M, et al. 2022. Life (Basel). 12:. PubMed Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed Qiu J, et al. 2016. Sci Rep. 6:39407. PubMed Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed Mariani SA, et al. 2019. Immunity. 50:1439. PubMed Yan J, et al. 2018. Nat Commun. 9:33. PubMed Kan C, et al. 2022. Bone Res. 10:62. PubMed Liao Y, et al. 2020. Mol Ther. 28:855. PubMed Hu M, et al. 2022. Can Respir J. 2022:5802938. PubMed Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed Xie Z, et al. 2021. Open Life Sci. 16:653. PubMed Wu L, et al. 2022. Front Cell Dev Biol. 9:684842. PubMed Chen X, et al. 2022. J Appl Oral Sci. 30:e20220316. PubMed Taguchi K, et al. 2015. J Urol. . PubMed Calvo B, et al. 2020. IBRO Rep. 8:36. PubMed Jin RM, et al. 2017. J Immunol. 198:352. PubMed Linde N, et al. 2018. Nat Commun. 9:21. PubMed Zhang P, et al. 2022. BMC Med. 20:435. PubMed Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed Feng T, et al. 2022. Nat Commun. 13:5208. PubMed Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed Rios-Doria J, et al. 2021. Front Oncol. 10:598477. PubMed Ayala TS, et al. 2019. Sci Rep. 9:11447. PubMed Mallampalli RK, et al. 2021. Front Immunol. 12:735576. PubMed Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed Xue N, et al. 2017. Sci Rep. 7:39011. PubMed Lee JY, et al. 2020. Nat Commun. 11:2358. PubMed Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed Wang Q, et al. 2018. Nat Commun. 9:559. PubMed Xu M, et al. 2022. Genes Dis. 9:429. PubMed Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed Reinfeld BI, et al. 2021. Nature. 593:282. PubMed Moya-Pérez A, et al. 2015. PLoS One. 10: 0126976. PubMed De Simone G, et al. 2021. Immunity. :. PubMed Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed Zhou X, et al. 2022. Front Pharmacol. 13:872188. PubMed Blriot C, et al. 2021. Immunity. :. PubMed Koikawa K, et al. 2021. Cell. 184:4753. PubMed Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed Sun S, et al. 2021. Front Immunol. 12:777665. PubMed Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed Zhang S, et al. 2021. J Inflamm Res. 14:4915. PubMed Sun M, et al. 2021. J Immunother Cancer. 9:. PubMed Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed Gubin MM, et al. 2018. Cell. 175:1014. PubMed Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed Remmerie A, et al. 2020. Immunity. 53:641. PubMed Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed Trott DW, et al. 2021. J Physiol. 599:3973. PubMed Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed Zhang Y, et al. 2020. Mol Med Rep. 22:534. PubMed Kiyohara H, et al. 2018. Cell Mol Gastroenterol Hepatol. 7:135. PubMed Guo D, et al. 2022. Bone Res. 10:45. PubMed Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed He H, et al. 2012. Blood. 120:3152. PubMed Dai K, et al. 2015. J Leukoc Biol. 98: 1071 - 1080. PubMed Settelmeier S, et al. 2020. PLoS One. 15:e0233261. PubMed Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed Rao L, et al. 2020. Nat Commun. 11:4909. PubMed Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed Lee SH, et al. 2018. J Exp Med. 215:357. PubMed Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed Tang PC, et al. 2022. Adv Sci (Weinh). 9:e2101235. PubMed Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed Canan C, et al. 2014. J Leukoc Biol. 96:473. PubMed Lee C, et al. 2020. Front Immunol. 11:77. PubMed Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed Piirainen S, et al. 2021. Glia. 69:2459. PubMed Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed Zhu Y, et al. 2021. Int J Oral Sci. 13:25. PubMed Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed Baardman J et al. 2018. Cell reports. 25(8):2044-2052 . PubMed Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed Liu Y, et al. 2019. Am J Physiol Cell Physiol. 317:C762. PubMed Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed Nasti A, et al. 2017. Eur J Immunol. 47:2163. PubMed Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed Ding T, et al. 2021. J Nanobiotechnology. 19:247. PubMed Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
RRID: AB_10896057 (BioLegend Cat. No. 141707) AB_10900231 (BioLegend Cat. No. 141708)
Structure: Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution: Macrophages, dendritic cells, Langerhans cells, liver endothelial cells
Function: Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor: Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type: Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area: Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family: CD Molecules
Antigen References: 1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501. 2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469. 3. Burgdorf S, et al. 2006. J. Immunol. 176:6770. 4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.
Gene ID: 17533
UniProt: View information about CD206 on UniProt.org
Clone: C068C2
Regulatory Status: RUO
Other Names: MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype: Rat IgG2a, κ
Q: Why is mouse CD206 stained intracellularly and not via surface staining?
A: Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.